DICTATE-AHF trial fails to meet primary endpoint with dapagliflozin in acute heart failure
Early initiation of the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalized patients ...
Aug 29, 2023
0
1